文献速递糖尿病

基线HbA1c识别高风险妊娠期糖尿病:在早期与标准妊娠期糖尿病中的效用

Baseline HbA1c to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该回顾性队列研究纳入1991至2011年澳大利亚皇家阿尔弗雷德王子医院糖尿病产前门诊的3098例妊娠期糖尿病孕妇,评估基线HbA1c与不良妊娠结局的关联。标准妊娠期糖尿病中HbA1c>5.9%(41 mmol/mol)与巨大儿、大于胎龄儿、剖宫产及高血压疾病风险增加相关;早期妊娠期糖尿病中类似关联存在,但较低HbA1c与小于胎龄儿风险相关。

要点

  • 标准妊娠期糖尿病中基线HbA1c>5.9%(41 mmol/mol)与大于胎龄儿、巨大儿、剖宫产及高血压疾病风险增加相关。
  • 早期妊娠期糖尿病中类似HbA1c关联可见,但较低HbA1c与小于胎龄儿风险相关(P趋势=0.004)。
  • 较高HbA1c水平在早期妊娠期糖尿病队列中作为分诊工具的效用有限。

核心结论

  • 基线HbA1c>5.9%(41 mmol/mol)可识别标准妊娠期糖尿病中大于胎龄儿、巨大儿、剖宫产及高血压疾病风险增加。
  • 早期妊娠期糖尿病中可见类似关联,但较高HbA1c水平不能充分捕捉风险,作为分诊工具效用有限。

研究设计与样本

  • 回顾性队列研究,1991至2011年在澳大利亚皇家阿尔弗雷德王子医院糖尿病产前门诊进行。
  • 共纳入3098例妊娠期糖尿病孕妇,诊断时进行单实验室HbA1c测量,母体临床及妊娠结局数据前瞻性收集。

主要发现

  • 早期妊娠期糖尿病(n=844)HbA1c测量中位孕周为17.6±3.3周,标准妊娠期糖尿病(n=2254)为29.4±2.6周。
  • 标准妊娠期糖尿病中HbA1c>5.9%(41 mmol/mol)与大于胎龄儿风险比为2.7(95%CI 1.5-4.9)、巨大儿为3.5(95%CI 1.4-8.6)、剖宫产为3.6(95%CI 2.1-6.2)、高血压疾病为2.6(95%CI 1.1-5.8)。
  • 早期妊娠期糖尿病中可见类似HbA1c关联,但较低HbA1c与小于胎龄儿风险相关(P趋势=0.004)及新生儿低血糖患病率相关。

关键数值与推荐

  • 标准妊娠期糖尿病中HbA1c>5.9%(41 mmol/mol)与大于胎龄儿、巨大儿、剖宫产及高血压疾病风险增加相关。
  • 早期妊娠期糖尿病中较低HbA1c与小于胎龄儿风险相关(P趋势=0.004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The increasing prevalence of gestational diabetes mellitus (GDM) necessitates risk stratification directing limited antenatal resources to those at greatest risk. Recent evidence demonstrates that an early pregnancy glycated hemoglobin (HbA1c ≥5.9% (41 mmol/mol) predicts adverse pregnancy outcomes. OBJECTIVE: To determine the optimal HbA1c threshold for adverse pregnancy outcomes in GDM in a treated multiethnic cohort and whether this differs in women diagnosed <24 vs ≥24 weeks' gestation (early vs standard GDM). DESIGN AND SETTING: This was a retrospective cohort study undertaken at the Royal Prince Alfred Hospital Diabetes Antenatal Clinic, Australia, between 1991 and 2011. PATIENTS AND INTERVENTIONS: Pregnant women (N = 3098) underwent an HbA1c (single-laboratory) measurement at the time of GDM diagnosis. Maternal clinical and pregnancy outcome data were collected prospectively. MAIN OUTCOME MEASURE: The association between baseline HbA1c and adverse pregnancy outcomes in early vs standard GDM. RESULTS: HbA1c was measured at a median of 17.6 ± 3.3 weeks' gestation in early GDM (n = 844) and 29.4 ± 2.6 weeks' gestation in standard GDM (n = 2254). In standard GDM, HbA1c >5.9% (41 mmol/mol) was associated with the greatest risk of large-for-gestational-age (odds ratio [95% confidence interval] = 2.7 [1.5-4.9]), macrosomia (3.5 [1.4-8.6]), cesarean section (3.6 [2.1-6.2]), and hypertensive disorders (2.6 [1.1-5.8]). In early GDM, similar HbA1c associations were seen; however, lower HbA1c correlated with the greatest risk of small-for-gestational-age (P trend = 0.004) and prevalence of neonatal hypoglycemia. CONCLUSIONS: Baseline HbA1c >5.9% (41 mmol/mol) identifies an increased risk of large-for-gestational-age, macrosomia, cesarean section, and hypertensive disorders in standard GDM. Although similar associations are seen in early GDM, higher HbA1c levels do not adequately capture risk-limiting utility as a triage tool in this cohort.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sweeting AN, Ross GP, Hyett J, et al. Baseline HbA1c to Identify High-Risk Gestational Diabetes: Utility in Early vs Standard Gestational Diabetes. J Clin Endocrinol Metab. 2017. PMID: 27797673. doi:10.1210/jc.2016-2951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。